At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Posted on: 13 March, 2023
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kol..... Read more
Category: New Treatment, Research Excellence
Posted on: 27 February, 2023
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than ..... Read more
Category: Research Excellence
Posted on: 20 February, 2023
A collection of emerging research leaders will have the chance to broaden their research experience ..... Read more
Category: Awards, Research Excellence